BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 24145135)

  • 1. Neuropsychological and neuroimaging phenotype induced by a CAMTA1 mutation.
    Magnin E; Blagosklonov O; Sylvestre G; Minot D; Thevenon J; Faivre L; Boulahdour H; Thauvin-Robinet C; Rumbach L
    Brain Dev; 2014 Sep; 36(8):711-5. PubMed ID: 24145135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intragenic CAMTA1 rearrangements cause non-progressive congenital ataxia with or without intellectual disability.
    Thevenon J; Lopez E; Keren B; Heron D; Mignot C; Altuzarra C; Béri-Dexheimer M; Bonnet C; Magnin E; Burglen L; Minot D; Vigneron J; Morle S; Anheim M; Charles P; Brice A; Gallagher L; Amiel J; Haffen E; Mach C; Depienne C; Doummar D; Bonnet M; Duplomb L; Carmignac V; Callier P; Marle N; Mosca-Boidron AL; Roze V; Aral B; Razavi F; Jonveaux P; Faivre L; Thauvin-Robinet C
    J Med Genet; 2012 Jun; 49(6):400-8. PubMed ID: 22693284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo variants in CAMTA1 cause a syndrome variably associated with spasticity, ataxia, and intellectual disability.
    Wijnen IGM; Veenstra-Knol HE; Vansenne F; Gerkes EH; de Koning T; Vos YJ; Tijssen MAJ; Sival D; Darin N; Vanhoutte EK; Oosterloo M; Pennings M; van de Warrenburg BP; Kamsteeg EJ
    Eur J Hum Genet; 2020 Jun; 28(6):763-769. PubMed ID: 32157189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intragenic CAMTA1 deletions are associated with a spectrum of neurobehavioral phenotypes.
    Shinawi M; Coorg R; Shimony JS; Grange DK; Al-Kateb H
    Clin Genet; 2015 May; 87(5):478-82. PubMed ID: 24738973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A combined neuropsychological and brain imaging study of obstructive sleep apnea.
    Yaouhi K; Bertran F; Clochon P; Mézenge F; Denise P; Foret J; Eustache F; Desgranges B
    J Sleep Res; 2009 Mar; 18(1):36-48. PubMed ID: 19250174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myoclonic dystonia phenotype related to a novel calmodulin-binding transcription activator 1 sequence variant.
    Dzinovic I; Serranová T; Prouteau C; Colin E; Ziegler A; Winkelmann J; Jech R; Zech M
    Neurogenetics; 2021 May; 22(2):137-141. PubMed ID: 33677721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calmodulin-binding transcription activator 1 (CAMTA1) alleles predispose human episodic memory performance.
    Huentelman MJ; Papassotiropoulos A; Craig DW; Hoerndli FJ; Pearson JV; Huynh KD; Corneveaux J; Hänggi J; Mondadori CR; Buchmann A; Reiman EM; Henke K; de Quervain DJ; Stephan DA
    Hum Mol Genet; 2007 Jun; 16(12):1469-77. PubMed ID: 17470457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanding the molecular spectrum and the neurological phenotype related to CAMTA1 variants.
    Jacobs EZ; Brown K; Byler MC; D'haenens E; Dheedene A; Henderson LB; Humberson JB; van Jaarsveld RH; Kanani F; Lebel RR; Millan F; Oegema R; Oostra A; Parker MJ; Rhodes L; Saenz M; Seaver LH; Si Y; Vanlander A; Vergult S; Callewaert B
    Clin Genet; 2021 Feb; 99(2):259-268. PubMed ID: 33131045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CAMTA1 T polymorphism is associated with neuropsychological test performance in older adults with cardiovascular disease.
    Miller LA; Gunstad J; Spitznagel MB; McCaffery J; McGeary J; Poppas A; Paul RH; Sweet LH; Cohen RA
    Psychogeriatrics; 2011 Sep; 11(3):135-40. PubMed ID: 21951953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of FLJ10737 and CAMTA1 genes on the commonly deleted region of neuroblastoma at human chromosome 1p36.31-p36.23.
    Katoh M; Katoh M
    Int J Oncol; 2003 Oct; 23(4):1219-24. PubMed ID: 12964007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allelic variants of CAMTA1 and FLJ10737 within a commonly deleted region at 1p36 in neuroblastoma.
    Henrich KO; Claas A; Praml C; Benner A; Mollenhauer J; Poustka A; Schwab M; Westermann F
    Eur J Cancer; 2007 Feb; 43(3):607-16. PubMed ID: 17222547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CAMTA1-related disorder: Phenotypic and molecular characterization of 26 new individuals and literature review.
    Al-Kateb H; Au PYB; Berland S; Cogne B; Demurger F; Fluss J; Isidor B; Frank LM; Varvagiannis K; Koolen DA; McDonald M; Montgomery S; Moortgat S; Deprez M; Karadurmus D; Paulsen J; Reis A; Rieger M; Vasileiou G; Willing M; Shinawi M
    Clin Genet; 2024 Mar; 105(3):294-301. PubMed ID: 38044714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broader phenotypic traits and widespread brain hypometabolism in spinocerebellar ataxia 27.
    Paucar M; Lundin J; Alshammari T; Bergendal Å; Lindefeldt M; Alshammari M; Solders G; Di Re J; Savitcheva I; Granberg T; Laezza F; Iwarsson E; Svenningsson P
    J Intern Med; 2020 Jul; 288(1):103-115. PubMed ID: 32112487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behr syndrome with homozygous C19ORF12 mutation.
    Kleffner I; Wessling C; Gess B; Korsukewitz C; Allkemper T; Schirmacher A; Young P; Senderek J; Husstedt IW
    J Neurol Sci; 2015 Oct; 357(1-2):115-8. PubMed ID: 26187298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CAMTA1, a 1p36 tumor suppressor candidate, inhibits growth and activates differentiation programs in neuroblastoma cells.
    Henrich KO; Bauer T; Schulte J; Ehemann V; Deubzer H; Gogolin S; Muth D; Fischer M; Benner A; König R; Schwab M; Westermann F
    Cancer Res; 2011 Apr; 71(8):3142-51. PubMed ID: 21385898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI-guided flumazenil- and FDG-PET in temporal lobe epilepsy.
    Szelies B; Weber-Luxenburger G; Pawlik G; Kessler J; Holthoff V; Mielke R; Herholz K; Bauer B; Wienhard K; Heiss WD
    Neuroimage; 1996 Apr; 3(2):109-18. PubMed ID: 9345482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Christianson syndrome: spectrum of neuroimaging findings.
    Bosemani T; Zanni G; Hartman AL; Cohen R; Huisman TA; Bertini E; Poretti A
    Neuropediatrics; 2014 Aug; 45(4):247-51. PubMed ID: 24285247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell cycle-dependent transcriptional regulation of calmodulin-binding transcription activator 1 in neuroblastoma cells.
    Nakatani K; Nishioka J; Itakura T; Nakanishi Y; Horinouchi J; Abe Y; Wada H; Nobori T
    Int J Oncol; 2004 Jun; 24(6):1407-12. PubMed ID: 15138581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of focus laterality in temporal lobe epilepsy: a quantitative study comparing double inversion-recovery MR imaging at 3T with FDG-PET.
    Morimoto E; Okada T; Kanagaki M; Yamamoto A; Fushimi Y; Matsumoto R; Takaya S; Ikeda A; Kunieda T; Kikuchi T; Paul D; Miyamoto S; Takahashi R; Togashi K
    Epilepsia; 2013 Dec; 54(12):2174-83. PubMed ID: 24117006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.